Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study

AIM: Emerging evidence has revealed that obstructive sleep apnea (OSA) is an independent risk factor for the development of a variety of adverse metabolic disease states. In this study, we evaluated the association between OSA severity and metabolic dysfunction-associated fatty liver disease (MAFLD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiefeng, Chen, Lida, Li, Xiuling, Chen, Menglan, Lin, Ting, Chen, Gongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985450/
https://www.ncbi.nlm.nih.gov/pubmed/36879664
http://dx.doi.org/10.2147/NSS.S398971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985450/
https://www.ncbi.nlm.nih.gov/pubmed/36879664
http://dx.doi.org/10.2147/NSS.S398971

Ejemplares similares